Amphotericin B resistance correlates with increased fitness in vitro and in vivo in Leishmania (Mundinia) martiniquensis
暂无分享,去创建一个
P. Somboon | A. Tantiworawit | P. Pescher | S. Roytrakul | G. Späth | C. Uthaipibull | P. Siriyasatien | N. Jariyapan | P. Tippawangkosol | Aphisek Kongkaew | C. Mano
[1] Wenbin Wei,et al. Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response , 2022, PLoS neglected tropical diseases.
[2] S. Murta/,et al. Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets , 2022, Frontiers in Cellular and Infection Microbiology.
[3] C. Fernández-Prada,et al. Identification of asymptomatic Leishmania infections: a scoping review , 2022, Parasites & Vectors.
[4] P. Bates,et al. Molecular identification of two newly identified human pathogens causing leishmaniasis using PCR-based methods on the 3′ untranslated region of the heat shock protein 70 (type I) gene , 2021, PLoS neglected tropical diseases.
[5] P. Somboon,et al. Experimental infection of Leishmania (Mundinia) martiniquensis in BALB/c mice and Syrian golden hamsters , 2020, Parasitology Research.
[6] P. Volf,et al. Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection , 2020, International journal for parasitology. Drugs and drug resistance.
[7] J. García-Martínez,et al. Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context , 2020, PLoS neglected tropical diseases.
[8] L. Maes,et al. Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection , 2020, Parasites & Vectors.
[9] P. Somboon,et al. Axenic amastigote cultivation and in vitro development of Leishmania orientalis , 2019, Parasitology Research.
[10] F. Gay,et al. Leishmaniasis , 2019, The Lancet.
[11] M. Barrett,et al. Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites , 2019, PLoS neglected tropical diseases.
[12] P. Somboon,et al. Leishmania (Mundinia) orientalis n. sp. (Trypanosomatidae), a parasite from Thailand responsible for localised cutaneous leishmaniasis , 2018, Parasites & Vectors.
[13] S. Castanys,et al. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs , 2018, International journal for parasitology. Drugs and drug resistance.
[14] H. Himmelbauer,et al. Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani , 2017, Nature Ecology & Evolution.
[15] M. Mungthin,et al. Prevalence and risk factors associated with Leishmania infection in Trang Province, southern Thailand , 2017, PLoS neglected tropical diseases.
[16] G. Bussotti,et al. Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression , 2017, mBio.
[17] T. Hortiwakul,et al. Early detection of novel Leishmania species DNA in the saliva of two HIV-infected patients , 2016, BMC Infectious Diseases.
[18] S. Rijal,et al. Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain , 2015, PloS one.
[19] A. Tantiworawit,et al. Chronic generalized fibrotic skin lesions from disseminated leishmaniasis caused by Leishmania martiniquensis in two patients from northern Thailand infected with HIV , 2015, The British journal of dermatology.
[20] M. Morales,et al. Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major , 2015, PLoS neglected tropical diseases.
[21] S. Castanys,et al. Fitness of Leishmania donovani Parasites Resistant to Drug Combinations , 2015, PLoS neglected tropical diseases.
[22] A. Tantiworawit,et al. First Isolation of Leishmania from Northern Thailand: Case Report, Identification as Leishmania martiniquensis and Phylogenetic Position within the Leishmania enriettii Complex , 2014, PLoS neglected tropical diseases.
[23] F. Pratlong,et al. Leishmania (Leishmania) martiniquensis n. sp. (Kinetoplastida: Trypanosomatidae), description of the parasite responsible for cutaneous leishmaniasis in Martinique Island (French West Indies) , 2014, Parasite.
[24] Atitaya Hitakarun,et al. Recurrences of visceral leishmaniasis caused by Leishmania siamensis after treatment with amphotericin B in a seronegative child. , 2014, The American journal of tropical medicine and hygiene.
[25] S. Castanys,et al. Leishmania donovani Develops Resistance to Drug Combinations , 2012, PLoS neglected tropical diseases.
[26] D. Singh,et al. Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani , 2011, Antimicrobial Agents and Chemotherapy.
[27] S. Sundar,et al. Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic , 2011, Journal of Clinical Microbiology.
[28] Xia Zhang,et al. The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.
[29] A. Ponte-Sucre,et al. Leishmania spp.: proficiency of drug-resistant parasites. , 2007, International journal of antimicrobial agents.
[30] M. Chance,et al. Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana , 2005, Antimicrobial Agents and Chemotherapy.
[31] L. A. Stauber,et al. An Eight‐day Method for Screening Compounds against Leishmania donovani in the Golden Hamster* , 1958 .